Integra Lifesciences Holdings (FRA:IL3) Additional Paid-In Capital : €1,206 Mil(As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Additional Paid-In Capital?

Integra Lifesciences Holdings's quarterly additional paid-in capital increased from Sep. 2023 (€1,183 Mil) to Dec. 2023 (€1,194 Mil) and increased from Dec. 2023 (€1,194 Mil) to Mar. 2024 (€1,206 Mil).

Integra Lifesciences Holdings's annual additional paid-in capital increased from Dec. 2021 (€1,119 Mil) to Dec. 2022 (€1,205 Mil) but then declined from Dec. 2022 (€1,205 Mil) to Dec. 2023 (€1,194 Mil).

Integra Lifesciences Holdings Additional Paid-In Capital Historical Data

The historical data trend for Integra Lifesciences Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Additional Paid-In Capital Chart

Integra Lifesciences Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,092.26

1,061.13

1,119.48

1,205.47

1,194.38

Integra Lifesciences Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,163.11	1,184.83	1,182.79	1,194.38	1,205.69

Integra Lifesciences Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Integra Lifesciences Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Integra Lifesciences Holdings (FRA:IL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

IART:USA

Address

1100 Campus Road, Princeton, NJ, USA, 08540

Website

https://www.integralife.com

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings (FRA:IL3) Headlines

No Headlines